PureTech Health (PRTC)
(Delayed Data from NSDQ)
$17.86 USD
-0.09 (-0.50%)
Updated Aug 8, 2025 12:35 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PRTC 17.86 -0.09(-0.50%)
Will PRTC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PRTC based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PRTC
DiaMedica Therapeutics CMO Lorianne Masuoka resigns, Julie Krop succeeds
PureTech Health (PRTC) Advances Phase 2b Trial for Depression Treatment | PRTC Stock News
PureTech Health doses first patient in BUOY-1 study
PRTC Crosses Above Key Moving Average Level